Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transfer of Donor-Derived Humoral Immunity Following Allogeneic Hematopoietic Stem Cell Transplantation

NCT01611298 is registered in ClinicalTrials.gov with Robert Krance as lead sponsor.

NCT NCT01611298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01611298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transfer of Donor-Derived Humoral Immunity Following Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Robert Krance
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2008
Completion date
July 31, 2013
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, hodgkin lymphoma, myelodysplastic syndrome, non-hodgkin lymphoma